The results of Cell Counting Kit-8 (CCK8) assays revealed that knockdown of PJA1 significantly increased the sensitivity of NPC cells to docetaxel (Fig. 1e) but not to cisplatin or 5-fluorouracil (Supplementary Fig. 2c, d). The gene discussed is PJA1; the disease is nasopharyngeal carcinoma.